ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AMLX Amylyx Pharmaceuticals Inc

1.78
-0.11 (-5.82%)
10 May 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 274.44M225.24M181.44M391.45M407.96M453.59M466.58M517.45M
Total Current Assets 265.49M216.14M172.2M382.13M389.05M427.39M434.11M464.67M
Cash and Equivalents 110.4M67.44M107.73M62.53M114.56M247.76M135.26M170.2M
Total Non-Current Assets 10.24M10.96M11.36M11.93M18.91M26.19M32.47M55.47M
Total Liabilities 33.49M32.45M37.42M50.85M55.31M67.22M48.18M84.02M
Total Current Liabilities 27.71M27.16M32.65M46.61M51.62M64.08M45.62M82.04M
Total Non-Current Liabilities 5.79M5.29M4.77M4.24M3.69M3.14M2.57M1.98M
Common Equity 6k6k6k7k7k7k7k7k
Retained Earnings -203.69M-257.76M-311.52M-354.22M-352.65M-330.57M-309.68M-304.95M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 3.22M14.1M105.61M391.45M517.45M
Total Current Assets 3.2M13.64M104.95M382.13M464.67M
Cash and Equivalents 3.07M12.88M50.19M62.53M170.2M
Total Non-Current Assets -25.36M-66.73M-151.17M340.61M433.43M
Total Liabilities 20.9M8.77M17.43M50.85M84.02M
Total Current Liabilities 4.53M7.33M17.4M46.61M82.04M
Total Non-Current Liabilities 31.3M1.7M35k4.24M1.98M
Total Equity -25.36M-66.73M-151.17M340.61M433.43M
Common Equity 1,0001,0001,0007k7k
Retained Earnings -25.63M-67.91M-155.85M-354.22M-304.95M